C12Y 301/01004
Phospholipase a2
Official title: Phospholipase A2 (3.1.1.4)
C12Y301/01004 (Phospholipase a2) appears on 124 US grants and 204 published applications in this corpus.
Search patents in C12Y- Granted patents
- 124
- Published applications
- 204
- Assignees
- 111
- Inventors
- 447
- Latest grant
- 31 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 2 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 3 | 0 |
| 1997 | 3 | 0 |
| 1998 | 1 | 0 |
| 1999 | 4 | 0 |
| 2000 | 3 | 0 |
| 2001 | 4 | 1 |
| 2002 | 10 | 6 |
| 2003 | 2 | 12 |
| 2004 | 3 | 8 |
| 2005 | 4 | 7 |
| 2006 | 1 | 5 |
| 2007 | 0 | 9 |
| 2008 | 3 | 8 |
| 2009 | 2 | 4 |
| 2010 | 2 | 5 |
| 2011 | 10 | 6 |
| 2012 | 3 | 11 |
| 2013 | 4 | 7 |
| 2014 | 5 | 6 |
| 2015 | 3 | 11 |
| 2016 | 8 | 6 |
| 2017 | 6 | 11 |
| 2018 | 6 | 6 |
| 2019 | 5 | 8 |
| 2020 | 5 | 9 |
| 2021 | 7 | 7 |
| 2022 | 2 | 8 |
| 2023 | 5 | 7 |
| 2024 | 4 | 12 |
| 2025 | 1 | 10 |
| 2026 | 1 | 14 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Reprogramming of lipid metabolism to inhibit T cell senescence and enhance tumor immunotherapy31 Mar 2026US 12,590,309 B2Saint Louis University
- Yeast expressing a heterologous phospholipase for ethanol production26 Aug 2025US 12,398,407 B2Novozymes A/S
- Production of par-baked products with improved freshness employing combination of GH8 xylanase and phospholipase12 Nov 2024US 12,137,695 B2Novozymes A/S
- Modified mammalian cells24 Sep 2024US 12,098,365 B2Genentech, Inc.
- Compositions comprising recombinant Bacillus cells and an insecticide25 Jun 2024US 12,016,912 B2Bayer CropScience AG
- Risankizumab compositions1 Oct 2026US 2026/0297178 A1AbbVie Inc.
- Risankizumab compositions24 Sep 2026US 2026/0285967 A1AbbVie Inc.
- Risankizumab compositions10 Sep 2026US 2026/0265366 A1AbbVie Inc.
- Compositions and methods for crossing the blood brain barrier27 Aug 2026US 2026/0250318 A1Voyager Therapeutics, Inc.
- Compositions and methods for treating cancer metastasis by administering nucleic acids encoding pleckstrin homology domains23 Jul 2026US 2026/0209295 A1The Johns Hopkins University
Most cited
By later US patents
- Pharmaceutical compositions containing giroxina and phospholipase A.sub.2 and methods of increasing a patient's CD.sub.4 count using the pharmaceutical compositions117US 5,676,974 A1997
- Oligonucleotide therapies for modulating the effects of herpes viruses91US 5,514,577 AIsis Pharmaceuticals, Inc. · 1996
- Type II phospholipase A2 and its use in killing Gram-positive bacteria63US 6,280,726 B1New York University · 2001
- Inhibitors of human immunodeficiency virus53US 5,523,389 AIsis Pharmaceuticals, Inc. · 1996
- Method of improving the properties of a flour dough, a flour dough improving composition and improved food products53US 6,358,543 B1Danisco A/S · 2002